RTI's TETRAfuse 3D Technology wins 2018 Spine Technology Award

NewsGuard 100/100 Score

RTI Surgical, Inc., a global surgical implant company, announced its TETRAfuse® 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week, a widely read publication in the orthopedics industry. RTI will accept the award at the North American Spine Society's (NASS) 33rd Annual Meeting taking place September 26-29, 2018 in Los Angeles and will be featured in upcoming issues of Orthopedics This Week and Orthopedics This Month Spine.

"RTI is honored to receive this important industry recognition, which is a testament to the ingenuity and dedication of our employees," said Camille Farhat, President and CEO, RTI Surgical. "TETRAfuse 3D Technology is one of many examples of RTI's commitment to the development and ongoing clinical research of innovative spine-focused solutions that meet the demands of surgeons and improve patient outcomes around the world."

TETRAfuse 3D Technology is an interbody fusion (IBF) device material, manufactured under an exclusive license with Oxford Performance Materials, designed to help drive optimal outcomes for patients undergoing spinal fusion procedures. It is the first 3D printed polymer-based IBF device material to incorporate a nano-rough surface that has demonstrated, in a pre-clinical study, more notable trabecular bone ingrowth compared to PEEK and titanium-coated PEEK.

TETRAfuse 3D Technology is featured in RTI's growing Fortilink® series of devices, including the Fortilink-C, -TS and -L IBF Systems. The devices are intended for use in interbody fusion procedures in patients with degenerative disc disease (DDD), an age-related condition when one or more discs between the vertebrae of the spinal column deteriorate or break down, which can lead to pain.

Those attending NASS can visit Booth #1523 to learn more about the Fortilink series of devices featuring TETRAfuse 3D Technology, as well as RTI's full line of high-quality hardware, interbody and orthobiologic spine offerings. For more information about the Fortilink IBF series of devices and TETRAfuse 3D Technology, visit www.tetrafuse3D.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations